Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
08/1999
08/05/1999WO1999039174A2 An automatic method of classifying molecules
08/05/1999WO1999039010A1 Eluting reagents, methods and kits for isolating dna
08/05/1999WO1999039000A1 Improved method for the isolation of nucleic acid
08/05/1999WO1999038963A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
08/05/1999WO1999038878A1 Novel synthons for oligonucleotide synthesis
08/05/1999WO1999038874A2 Electrophoretic nucleic acid purification method
08/05/1999WO1999019359A8 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
08/05/1999WO1999015542A3 Linker nucleoside, and production and use of the same
08/05/1999WO1999014226A3 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
08/05/1999WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules
08/05/1999CA2319710A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
08/05/1999CA2318973A1 Electrophoretic nucleic acid purification method
08/05/1999CA2318748A1 Novel synthons for oligonucleotide synthesis
08/05/1999CA2317055A1 Improved method for the isolation of nucleic acid
08/04/1999EP0932668A1 Two human cathepsin proteins
08/04/1999EP0871644A4 Platelet-endothelial cell adhesion molecule-1 compositions and methods
08/04/1999EP0702729A4 Chemical process for amplifying and detecting nucleic acid sequences
08/04/1999EP0642761B1 Ct system for quantitatively determining bone mineral mass
08/04/1999EP0365657B1 Dna encoding androgen receptor protein
08/04/1999CN1225127A Vectors and methods for tissue specific synthesis of protein in eggs of transgenic hens
08/04/1999CN1225019A Inhibition of Ii synthesis
08/03/1999US5932718 Oligonucleotides having modified internucleoside linkages or terminal amino group
08/03/1999US5932711 Nucleic acid-containing polymerizable complex
08/03/1999US5932557 Adenosine A1 receptor antisense oligonucleotide treatment of alcohol and marijuana-induced psychomotor impairments
08/03/1999US5932540 Vascular endothelial growth factor 2
08/03/1999US5932477 This novel enzyme is particularly useful for screening candidate compounds for their ability to serve as potential anti-depressant, antiasthmatic or anti-inflammatory agents.
08/03/1999US5932476 Cloning of chicken anemia virus DNA
08/03/1999US5932471 DNA encoding chimeric toxin
08/03/1999US5932453 Nucleic acid sequence that codes for mutant aspartokinase gene with no feedback inhibition by l-lysine
08/03/1999US5932447 Use of purified oligonucleotides encoding the ribosome-inactivating protein for the expression of a ribosome-inactivating protein (rip) and in the construction of fusion proteins is also considered part of the present
08/03/1999US5932219 Polypeptides
08/03/1999US5932213 Modified plasmin precursors with resistance to inhibitors of plasmin
08/03/1999CA1340689C Human b-cell differentiation factor and process of producing said factor
07/1999
07/29/1999WO1999038008A1 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
07/29/1999WO1999037810A1 A method, reagent solution and kits for dna sequencing
07/29/1999WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
07/29/1999WO1999037780A1 Expression of the insl4 gene in human embryonic bone tissues and applications
07/29/1999WO1999037717A1 Asymmetric cyanine dye quenchers
07/29/1999WO1999012951A9 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
07/29/1999CA2319076A1 Expression of the insl4 gene in human embryonic bone tissues and applications
07/29/1999CA2318352A1 Diagnosis and treatment of aur1 and/or aur2 related disorders
07/28/1999EP0931165A1 Measurement of gene expression profiles in toxicity determination
07/28/1999EP0931090A1 Improved chimeric oligonucleotide vectors
07/28/1999EP0931089A1 A method of separating a two phase system
07/28/1999EP0931038A1 Novel substance library and supramolecular complexes produced therewith
07/28/1999EP0864002A4 Methods and compositions for detection of specific nucleotide sequences
07/28/1999EP0852617A4 Apparatus and methods for active programmable matrix devices
07/28/1999EP0743958A4 Non-viral vector
07/28/1999EP0736103A4 Nucleotide-directed assembly of bimolecular and multimolecular drugs and devices
07/28/1999EP0698093B1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE
07/28/1999EP0131623B2 Chimeric genes suitable for expression in plant cells
07/27/1999US5929226 Three or more but not all nucleotides are connected with methylphosphonothioate linkages where sulfur is not bridging atom; increased resistance to nucleases, increased duplex stability
07/27/1999US5929224 Dna encoding human white blood cell activating proteins; useful in diagnosis as anticarcinogenic agents
07/27/1999US5929213 Antibodies to growth differentiation factor-12
07/27/1999US5929208 Combinatorial synthesis of biopolymers by contacting substrate with solution of monomer a, selectively biasing locations to specifically concentrate monomer a, removing unreacted monomer a, repeating with other monomers
07/27/1999US5929108 Detecting dna and rna sequence comprising hybridizing a probe with compementary regions of said dna and rna sequence, wherein the probe is a nucleic acid sequence labeled with digoxigenin derivative-spacer-furocoumarins complex label
07/27/1999US5929040 Method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
07/27/1999US5928922 Proteins and polynucleotides used in the production of recombinant collagen
07/27/1999US5928921 Nucleotide sequence of enzyme which oxidizes xenobiotics; for evaluating human xenobiotic metabolism in vitro
07/27/1999US5928919 Mutant family b enzymes with reduced or non 3' to 5' exonuclease activity; for high quality (sanger) chain stopping sequencing reactions
07/27/1999US5928893 Monoclonal antibody specific for human 4-1BB and cell line producing same
07/27/1999US5928890 Human amine receptor
07/27/1999US5928862 Competitive homogeneous assay
07/27/1999CA2167520C Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
07/22/1999WO1999036544A2 Neisseria meningitidis antigens
07/22/1999WO1999036518A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4
07/22/1999WO1999036508A1 Histidine kinase
07/22/1999WO1999036429A2 Nucleobase oligomers
07/22/1999WO1998055495B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
07/22/1999CA2317895A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4
07/22/1999CA2317815A1 Neisseria meningitidis antigens
07/22/1999CA2317677A1 Nucleobase oligomers
07/21/1999CN1223661A Plant plastid division genes
07/21/1999CN1223660A Method and compounds for curing diseases caused by mutations
07/21/1999CN1223549A Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
07/20/1999US5925749 Isolated oligonucletide; for hybridization probes to isolate heat resistant enzyme
07/20/1999US5925744 Macrocyclic compound for sequence cleavage of rna
07/20/1999US5925740 Antibodies to receptor for oncostatin M
07/20/1999US5925732 Chemical reaction apparatus for performing multiple reaction on a surface and collecting the product
07/20/1999US5925623 Formulations and methods for generating active cytofectin: polynucleotide transfection complexes
07/20/1999US5925525 Method of identifying nucleotide differences
07/20/1999US5925517 Hybridization probe of single-stranded sequence complementary to target, flanked by oligonucleotide arms with interacting labels capable of forming stem duplex; hybridization with target alters level of signal at least ten percent
07/15/1999WO1999035289A1 Polymeric arrays and methods for their use in binding assays
07/15/1999WO1999035261A1 Novel gene having reverse transcriptase motif
07/15/1999WO1999022020A3 Labelling of polymers and sequencing of nucleic acids
07/15/1999CA2312848A1 Polymeric arrays and methods for their use in binding assays
07/14/1999EP0928419A1 Compositions and methods for modulating type i interleukin-1 receptor expression
07/14/1999EP0928341A1 Method for screening compounds which interact with the l-enantiomer of a target rna
07/14/1999EP0928339A1 Mammalian artificial chromosomes
07/14/1999EP0928335A2 METHOD FOR USING OLIGONUCLEOTIDES HAVING MODIFIED CpG DINUCLEOSIDES
07/14/1999EP0928290A1 Oligoribonucleotides and ribonucleases for cleaving rna
07/14/1999EP0759079B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel-III)
07/14/1999CN1222914A High molecular weight surface proteins of non-typeable haemophilus
07/14/1999CN1044133C Process for preparing nucleotide series corresponding to human erythropoietin gene fragment
07/13/1999US5922858 Misaminoacylated transfer ribonucleic acid with photocleavable marker; for incorporation of non-radioactive labels into nascent proteins by cellular or cell-free translation systems
07/13/1999US5922854 Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids
07/13/1999US5922841 Recombinantly produced transferrin receptor of haemophilus
07/13/1999US5922686 Nucleotide sequences and hybridization and protein c and kinases
07/13/1999US5922600 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor
07/13/1999US5922578 Recombinant thermostable enzyme which forms non-reducing saccharide from reducing amylaceous saccharide